List of 101 Pharmaceutical products Comprising Drugs, Eye drops Banned by NAFDAC

The National Agency For Food and Drug Administration and Control (NAFDAC) recently withdrew its approval for 101 products owing to different reasons.

Pharmaceutical products dominated the list of banned products ranging from tablets, syrrups to eye drops. Here is the full list below.

S/N Product Name Dosage Form NAFDAC Number Active Ingredients Market Authorization Holder Application Purpose
1 Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg Tablets C4-1180 Abacavir Sulfate, Lamivudine Healthline Limited Withdrawn Voluntarily by Market Authorization Holder
2 Amaryl M Tablets Tablets A4-2619 Glimepiride, Metformin Hydrochloride Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
3 Amaryl M SR Tablets Tablets A4-7296 Glimepiride, Metformin Hydrochloride Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
4 Aprovasc 150mg/5mg Tablets Tablets B4-2687 Amlodipine Besylate, Irbesartan Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
5 Artemether/Lumefantrine 40mg/240mg Tablets Tablets B4-5745 Artemether, Lumefantrine Healthline Limited Withdrawn Voluntarily by Market Authorization Holder
6 ASAQ (Artesunate Amodiaquine Winthrop) 100mg/270mg Tablets Tablets A4-3357 Artesunate, Amodiaquine Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
7 ASAQ (Artesunate Amodiaquine Winthrop) 25mg/67.5mg Tablets Tablets A4-3406 Artesunate, Amodiaquine Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
8 ASAQ (Artesunate Amodiaquine Winthrop) 50mg/135mg Tablets Tablets A4-3405 Artesunate, Amodiaquine Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
9 Betopic Eye Drop Eye Drop 04-2404 Betaxolol Hydrochloride Novartis Nigeria Limited Withdrawn Voluntarily by Market Authorization Holder
10 Coaprovel 300mg/25mg Tablets Tablets B4-2317 Hydrochlorothiazide, Irbesartan Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
11 Combination 3 Tablets Tablets A4-6459 Estrogen, Progestin Bayer East Africa Limited Withdrawn Voluntarily by Market Authorization Holder
12 Efavirenz 600mg Tablets Tablets A4-1318 Efavirenz Healthline Limited Withdrawn Voluntarily by Market Authorization Holder
13 Elisca Eye Drop Eye Drop 04-2461 Chloramphenicol Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
14 Flagyl Suspension Suspension A4-3947 Metronidazole Benzoate Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
15 Flagyl Tablet 400mg Tablets 04-5566 Metronidazole Sanofi Aventis Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
16 Iliadin Adult 0.05% Metered Nose Spray Spray B4-9913 Oxymetazoline HCl 0.05% M/V Fensyl MHP Consulting Ltd Withdrawn Voluntarily by Market Authorization Holder
17 Iliadin Baby 0.01% Nose Drops Spray C4-0106 Oxymetazoline HCl 0.01% M/V Fensyl MHP Consulting Ltd Withdrawn Voluntarily by Market Authorization Holder
18 Iliadin Kids 0.025% Nose Drops Spray B4-9912 Oxymetazoline HCl 0.025% M/V Fensyl MHP Consulting Ltd Withdrawn Voluntarily by Market Authorization Holder
19 Invanz 1g Injections Injectables 04-8118 Ertapenem MSD Idea Pharmaceuticals Nigeria Ltd Withdrawn Voluntarily by Market Authorization Holder
20 Invega (Paliperidone) 3mg Extended Release Tablets Tablets B4-8223 Paliperidone Janssen Pharmaceutical Companies Withdrawn Voluntarily by Market Authorization Holder
41 Uptivite Man Tablets A7-101014L Supplement Gentlehills Limited Cancelled by NAFDAC
42 Mist Alba Suspension Suspension A11-0871 Magnesium Sulphate Gentlehills Limited Cancelled by NAFDAC
43 Gentle Hill Cough Syrup Syrup A11-0872 Diphenhydramine HCl, Ammonium Chloride, Menthol, Sodium Citrate Gentlehills Limited Cancelled by NAFDAC
44 Gentlehills Vitamin C Syrup Syrup A11-0936 Ascorbic Acid Gentlehills Limited Cancelled by NAFDAC
101 Mektovi 15mg Tablets Tablets A4-100332 Binimetinib 15mg Pfizer Specialties Limited Withdrawn Voluntarily by Market Authorization Holder

 

Share this article

Leave a Reply

Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Newsletter

Get notified about new articles